Do breast cancer survivors' post-surgery difficulties with recreational activities persist over time?
- 259 Downloads
Most longitudinal breast cancer studies have found that treatment-related sequelae such as arm morbidity [lymphedema, pain, and range of motion (ROM) restrictions] can have a significant impact on quality of life. In a previous study, we found that at 6–12 months after breast cancer surgery, 49% of participants had difficulties engaging in recreational activities and that arm morbidity significantly predicted difficulties with participation in recreation.
A longitudinal national study employing clinical assessments and survey methods followed 178 women over 43 months (3.6 years) to assess issues related to arm morbidity post-breast cancer surgery. Hierarchical multiple regression analyses were conducted to identify which variables were predictive of recreational difficulties experienced by women 8 and 43 months post-surgery.
Between 8 months (T1) and 43 months (T2) post-breast cancer surgery, women demonstrated slight increases in lymphedema. Conversely, a significant decrease was observed in the number of ROM restrictions and pain when using the arm. Despite the overall improvements in arm morbidity, some women continued to report moderate pain and ROM restrictions. The two arm morbidity factors were found to be statistically significant (p < 0.001) predictors of recreational difficulties at both 8 and 43 months post-surgery, with pain accounting for the greatest proportion of variance.
Pain and ROM restrictions were the only significant predictors of recreational difficulties during the first 3.6 years after breast cancer surgery. Specifically, women who still experience pain years after breast cancer surgery report difficulties in their recreational pursuits.
Implications for cancer survivors
Pain and ROM restrictions may prohibit participation in recreational activity and targeted intervention should be sought.
KeywordsBreast cancer Arm morbidity Recreation Pain Lymphedema Longitudinal
Canadian Institute of Health Reasearch MOP 94574.
- 1.Ellison LF, Wilkins K. An update on cancer survival. Statistics Canada Health Reports. 2010;21(3):1–6.Google Scholar
- 17.International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36(2):84–91.Google Scholar
- 18.Thomas-MacLean R, Spriggs P, Quinlan E, Towers A, Hack T, Tatemichi S, et al. Arm morbidity and disability: current status in Canada. J Lymphoedema. 2010;5(2):33–8.Google Scholar
- 21.Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001;14(2):128–46.PubMedGoogle Scholar